Legends Health And Wellness
- PRP Therapy
- IV Therapy
- Arthritis Treatment
- Peptide Therapy
- Hormone Replacement Therapy (HRT)
Jacksonville, FL
Jacksonville stem-cell marketing clusters where cash-pay orthopedics, wellness suites, and First Coast medical traffic meet naval and port schedules, snowbird winters, and humid subtropical recovery habits. You will see same-day bone marrow or adipose products, cord-blood marketing, and "regenerative" injection menus across Riverside and San Marco offices, Southside and Town Center suites, Beaches practices (Jacksonville Beach, Neptune Beach, Atlantic Beach), and Orange Park or Mandarin spillover that still filters under the Jacksonville Directory. The same "stem cell" label can mean very different cell sources, processing steps, and evidence grades.
This hub lists clinics that appear in our Directory for Jacksonville and stem-cell therapy. Inclusion is not an endorsement, and listing order is not a paid ranking. Regenerated.com is free for patients. Organic relevance and published evidence signals are separate from any labeled Featured or Sponsored placement. Verified badges, when present, reflect credential checks (not spend).
When you compare options here, ask what product is actually injected, whether it is same-day autologous or banked allogeneic material, who performs the procedure, what imaging guides it, and which outcomes they track. Proximity to Mayo Clinic Jacksonville, UF Health Jacksonville, or Baptist Health is not the same as a private-clinic protocol. Regenerated does not invent Jacksonville average prices; clinic quotes vary too widely by product and body site for a single range to be honest.
Prefer clinicians who can explain FDA IND/BLA boundaries in plain language, document informed consent, and separate marketing claims from published evidence. Use national stem-cell Guides for mechanism literacy, then return here for Jacksonville listings.
Regulatory context
Florida cellular therapy providers are governed by 21 CFR Part 1271. Section 361 applies to minimally manipulated HCT/Ps used for homologous use without premarket approval. Section 351 applies to products that are more than minimally manipulated, used non-homologously, or combined with another article, and these require an IND or BLA. Most stem cell, stromal vascular fraction, exosome, umbilical cord blood derived, and culture-expanded mesenchymal cell therapies marketed in Florida for orthopedic, neurologic, autoimmune, and longevity indications fall under Section 351 and lack FDA approval. Florida is a high-volume market, which has translated into elevated federal scrutiny.
Florida has been a primary target of FDA enforcement. In US v US Stem Cell Inc (2019), a federal court in Florida granted a permanent injunction against a Sunrise-based clinic for marketing unapproved stem cell products derived from adipose tissue. The Eleventh Circuit upheld the injunction in 2021. The FDA has issued multiple warning letters to Florida clinics offering exosome and umbilical cord-derived therapies. The Florida Department of Health and the Boards of Medicine and Osteopathic Medicine have disciplined physicians for unprofessional conduct tied to misleading regenerative medicine marketing. The Florida Attorney General has pursued deceptive trade practice claims under FDUTPA against stem cell clinics.
Available here
Nationwide
Stem Cell Therapy clinics across the US